Kmah Lifescience Private Limited
About Kmah Lifescience Private Limited
Data last updated:
Kmah Lifescience Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 04 November 2022.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24290GJ2022PTC136538.
The company has an authorised share capital of ₹1.2 Lakh and a paid-up capital of ₹1.2 Lakh. It is led by directors Maitri Jatinkumar Shah and Bhavik Arvindbhai Shah.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Ahmedabad, Gujarat.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.14 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹2.63 Lakh (net margin 0.6%) and EBITDA of ₹4.36 Lakh (EBITDA margin 1.1%).
As per MCA filings, the company has open charges of ₹97 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Kmah Lifescience Private Limited's registered office is in Ahmedabad, Gujarat.
- Registered AddressA – 208 Titanium Square B/H Sarveswar Tower, Thalej Four Way Thaltej, Ahmedabad, Gujarat, India – 380054
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Kmah Lifescience is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Kmah Lifescience Private Limited, buy the company report.
Financials of Kmah Lifescience Private Limited
FY 2025 filings availableKmah Lifescience Private Limited reported revenue of ₹4.14 Cr (up 52432% YoY) for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹4.36 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹2.63 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 1.1% | ||
| Net Profit Margin | 0.6% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Kmah Lifescience Private Limited, buy the company report.
Board of directors of Kmah Lifescience Private Limited
Kmah Lifescience has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Maitri Jatinkumar Shah Also directs: Adleve Healthcare LLP | Director | 04 Nov 2022 | 3 Years 11 Months | Current |
| Bhavik Arvindbhai Shah Also directs: Caper Lifescience LLP, Zynex Lifescience LLP, Trinix Pharma Private Limited and 1 more | Director | 04 Nov 2022 | 3 Years 11 Months | Current |
Peer comparison
Kmah Lifescience Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mandore Pharma Private Limited | ₹4.16 Cr (FY 2025) | 140.0% | Shamli, Uttar Pradesh, India | |||
| Phoenix Remedies Private Limited | ₹4.14 Cr (FY 2024) | 9.0% | Ahmedabad, Gujarat, India | |||
| Kmah Lifescience Private Limitedthis company | ₹4.14 Cr (FY 2025) | ₹2.63 Lakh | 0.6% | 52432.0% | Ahmedabad, Gujarat, India | |
| Nadine Healthcare Private Limited | ₹4.14 Cr (FY 2025) | 3.0% | Kanpur, Uttar Pradesh, India | |||
| Vivrthi Labs Private Limited | ₹4.14 Cr (FY 2024) | -6.0% | Hyderabad, Telangana, India | |||
| Rus-Med Exports Private Limited | ₹4.13 Cr (FY 2025) | 29.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Kmah Lifescience Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 29 Aug 2025 | 101165022 | Canara Bank | ₹97 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Kmah Lifescience Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Kmah Lifescience Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Kmah Lifescience Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Kmah Lifescience Private Limited has 3 board changes on record since 2022: 2 appointments and 1 cessation. The latest: Shanal Gaurangbhai Shah ceased to be Director on 21 May 2024.
Frequently asked questions
Kmah Lifescience is an active private limited company based in Ahmedabad, Gujarat, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 04 November 2022 (4+ years old) and is registered under CIN U24290GJ2022PTC136538.
Kmah Lifescience has 2 current directors:
- Maitri Jatinkumar Shah - Director
- Bhavik Arvindbhai Shah - Director
The latest financial statements of Kmah Lifescience on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Kmah Lifescience is U24290GJ2022PTC136538. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kmah Lifescience was incorporated on 04 November 2022, making it 4+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Kmah Lifescience by revenue are Mandore Pharma Private Limited, Phoenix Remedies Private Limited, Nadine Healthcare Private Limited, Vivrthi Labs Private Limited, Rus-Med Exports Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).
Shanal Gaurangbhai Shah ceased to be Director on 21 May 2024. Bhavik Arvindbhai Shah was appointed as Director on 04 Nov 2022. Maitri Jatinkumar Shah was appointed as Director on 04 Nov 2022.
The registered office of Kmah Lifescience is at A – 208 Titanium Square BH Sarveswar Tower, Thalej Four Way Thaltej, Ahmedabad, Gujarat, India – 380054.
Kmah Lifescience operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Kmah Lifescience has open charges of ₹97 Lakh and no satisfied charges on record as per latest MCA filings.
The compliance status of Kmah Lifescience is compliant as of 11 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
